Related Experiment Video
Updated: Aug 24, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Liver transplantation from old donors into HCV and non-HCV recipients
U Baccarani1, G L Adani, P Toniutto
1Department of Surgery and Transplantation Unit, Udine, Italy.
Insights
Liver transplantation using elderly donors (>65 years) shows worse outcomes for Hepatitis C Virus (HCV)-positive recipients compared to younger donors. These older donor livers are best reserved for non-HCV patients.
Area of Science:
- Hepatology
- Transplantation Surgery
- Virology
Background:
- Chronic liver failure from Hepatitis C Virus (HCV)-related cirrhosis is a primary driver for liver transplantation in Western nations.
- Liver transplantation outcomes in HCV patients are often inferior, particularly when utilizing marginal donor organs.
- Elderly donors represent a growing, yet potentially marginal, donor pool.
Purpose of the Study:
- To retrospectively evaluate the impact of elderly donor age (>65 years) on liver transplantation outcomes in HCV-positive versus non-HCV recipients.
- To compare patient and graft survival rates between HCV-positive and non-HCV recipients of elderly donor livers.
- To identify potential risk factors associated with using elderly donor grafts in liver transplantation.
Main Methods:
- A retrospective analysis of 179 patients undergoing 204 liver transplantations.
- Patients were stratified into four groups based on HCV status and donor age (>65 years).
- Kaplan-Meier method was employed to calculate long-term patient and graft survival rates.
Main Results:
- Liver grafts from donors >65 years into HCV-positive recipients demonstrated significantly lower patient and graft survival rates (40% vs 78% and 40% vs 68%, respectively) compared to those from younger donors.
- HCV-positive recipients of elderly donor grafts had poorer outcomes than non-HCV recipients, despite higher rates of macrosteatosis in organs used for non-HCV cases (55% vs 9%).
- The study noted a trend towards lower graft survival (P=.06) in HCV-positive recipients of older donor livers.
Conclusions:
- Liver transplantation using donor grafts from individuals >65 years of age is associated with worse outcomes in HCV-positive recipients compared to younger donors.
- The findings suggest that elderly donor livers may be best reserved for non-HCV recipients to optimize transplant success.
- While the study was limited by a small cohort of patients receiving older donor livers, the results highlight the importance of donor age in liver transplantation for HCV-positive individuals.
Background:
Chronic liver failure due to HCV-related cirrhosis is the leading indication for liver transplantation in Western countries. Inferior long-term results have been reported for liver transplantation in HCV patients, especially when marginal donor livers are utilized. The aim of this study was to retrospectively analyze the outcome of liver transplantation from elderly donors in HCV versus non-HCV recipients.
Methods:
One hundred seventy-nine patients receiving 204 liver transplantations were divided into four groups according to HCV positivity and donor age (> or <65 years). Long-term survivals were calculated by the Kaplan-Meier method.
Results:
Grafts from donors of >65 years into HCV-positive patients displayed lower patient and graft survival rates than HCV-negative cases, although macrosteatosis was more frequent (55% vs 9%, P =.02) among organs used for non-HCV cases. Moreover, HCV-positive recipients transplanted with a donor aged >65 years had significantly lower patient and graft survival (40% vs 78% [P =.01] and 40% vs 68% [P =.06], respectively) than patients receiving a liver from a younger donor.
Conclusions:
Our retrospective analysis, although hampered by a small number of patients transplanted with an old liver, suggest that the results of liver transplantation with a donor graft >65 years of age into an HCV-positive recipient shows a worse outcome than those from younger donors. Older livers should be reserved for non-HCV cases.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
